Literature DB >> 23178493

Essential role of cooperative NF-κB and Stat3 recruitment to ICAM-1 intronic consensus elements in the regulation of radiation-induced invasion and migration in glioma.

D Kesanakurti1, C Chetty, D Rajasekhar Maddirela, M Gujrati, J S Rao.   

Abstract

Although radiotherapy improves survival in patients, glioblastoma multiformes (GBMs) tend to relapse with augmented tumor migration and invasion even after ionizing radiation (IR). Aberrant nuclear factor-κB (NF-κB) and signal transducer and activator of transcription factor 3 (Stat3) activation and interaction have been suggested in several human tumors. However, possible NF-κB/Stat3 interaction and the role of Stat3 in maintenance of NF-κB nuclear retention in GBM still remain unknown. Stat3 and NF-κB (p65) physically interact with one another in the nucleus in glioma tumors. Most importantly, glutathione S-transferase pull-down assays identified that Stat3 binds to the p65 transactivation domain and is present in the NF-κB DNA-binding complex. Irradiation significantly elevated nuclear phospho-p65/phospho-Stat3 interaction in correlation with increased intercellular adhesion molecule-1 (ICAM-1) and soluble-ICAM-1 levels, migration and invasion in human glioma xenograft cell lines 4910 and 5310. Chromatin immunopreicipitation and promoter luciferase activity assays confirmed the critical role of adjacent NF-κB (+399) and Stat3 (+479) binding motifs in the proximal intron-1 in elevating IR-induced ICAM-1 expression. Specific inhibition of Stat3 or NF-κB with Stat3.siRNA or JSH-23 severely inhibited IR-induced p65 recruitment onto ICAM-1 intron-1 and suppressed migratory properties in both the cell lines. On the other hand, Stat3C- or IR-induced Stat3 promoter recruitment was significantly decreased in p65-knockdown cells, thereby suggesting the reciprocal regulation between p65 and Stat3. We also observed a significant increase in NF-κB enrichment on ICAM-1 intron-1 and ICAM-1 transactivation in Stat3C overexpressing cells. In in vivo orthotopic experiments, suppression of tumor growth in Stat3.si+IR-treated mice was associated with the inhibition of IR-induced p-p65/p-Stat3 nuclear colocalization and ICAM-1 levels. To our knowledge, this is the first study showing the crucial role of NF-κB/Stat3 nuclear association in IR-induced ICAM-1 regulation and implies that targeting NF-κB/Stat3 interaction may have future therapeutic significance in glioma treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23178493      PMCID: PMC3664652          DOI: 10.1038/onc.2012.546

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  51 in total

1.  Radiation enhances long-term metastasis potential of residual hepatocellular carcinoma in nude mice through TMPRSS4-induced epithelial-mesenchymal transition.

Authors:  T Li; Z-C Zeng; L Wang; S-J Qiu; J-W Zhou; X-T Zhi; H-H Yu; Z-Y Tang
Journal:  Cancer Gene Ther       Date:  2011-06-03       Impact factor: 5.987

Review 2.  NF-kappaB modulation and ionizing radiation: mechanisms and future directions for cancer treatment.

Authors:  Nicolas Magné; Robert-Alain Toillon; Virginie Bottero; Céline Didelot; Paul Van Houtte; Jean-Pierre Gérard; Jean-François Peyron
Journal:  Cancer Lett       Date:  2006-01-18       Impact factor: 8.679

Review 3.  Shared principles in NF-kappaB signaling.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Cell       Date:  2008-02-08       Impact factor: 41.582

Review 4.  Crosstalk in NF-κB signaling pathways.

Authors:  Andrea Oeckinghaus; Matthew S Hayden; Sankar Ghosh
Journal:  Nat Immunol       Date:  2011-07-19       Impact factor: 25.606

5.  Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma.

Authors:  Lloyd T Lam; George Wright; R Eric Davis; Georg Lenz; Pedro Farinha; Lenny Dang; John W Chan; Andreas Rosenwald; Randy D Gascoyne; Louis M Staudt
Journal:  Blood       Date:  2007-12-26       Impact factor: 22.113

Review 6.  Molecular pathology of malignant gliomas.

Authors:  David N Louis
Journal:  Annu Rev Pathol       Date:  2006       Impact factor: 23.472

7.  ICAM-1 expression determines malignant potential of cancer.

Authors:  Christina L Roland; Alden H Harken; Michael G Sarr; Carlton C Barnett
Journal:  Surgery       Date:  2007-06       Impact factor: 3.982

8.  Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-kappaB-dependent DNA methyltransferase activity in acute myeloid leukemia.

Authors:  Shujun Liu; Zhongfa Liu; Zhiliang Xie; Jiuxia Pang; Jianhua Yu; Esther Lehmann; Lenguyen Huynh; Tamara Vukosavljevic; Mitsui Takeki; Rebecca B Klisovic; Robert A Baiocchi; William Blum; Pierluigi Porcu; Ramiro Garzon; John C Byrd; Danilo Perrotti; Michael A Caligiuri; Kenneth K Chan; Lai-Chu Wu; Guido Marcucci
Journal:  Blood       Date:  2007-12-14       Impact factor: 22.113

9.  MMP-2 siRNA inhibits radiation-enhanced invasiveness in glioma cells.

Authors:  Aruna Venkata Badiga; Chandramu Chetty; Divya Kesanakurti; Deepthi Are; Meena Gujrati; Jeffrey D Klopfenstein; Dzung H Dinh; Jasti S Rao
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

10.  Role of MMP-2 in the regulation of IL-6/Stat3 survival signaling via interaction with α5β1 integrin in glioma.

Authors:  D Kesanakurti; C Chetty; D H Dinh; M Gujrati; J S Rao
Journal:  Oncogene       Date:  2012-02-20       Impact factor: 9.867

View more
  60 in total

1.  A Prognostic Signature for Lower Grade Gliomas Based on Expression of Long Non-Coding RNAs.

Authors:  Manjari Kiran; Ajay Chatrath; Xiwei Tang; Daniel Macrae Keenan; Anindya Dutta
Journal:  Mol Neurobiol       Date:  2018-11-03       Impact factor: 5.590

Review 2.  NF-κB and STAT3 in glioblastoma: therapeutic targets coming of age.

Authors:  G Kenneth Gray; Braden C McFarland; Susan E Nozell; Etty N Benveniste
Journal:  Expert Rev Neurother       Date:  2014-09-29       Impact factor: 4.618

3.  Dual Functional MicroRNA-186-5p Targets both FGF2 and RelA to Suppress Tumorigenesis of Glioblastoma Multiforme.

Authors:  Fachen Wang; Hui Jiang; Shanjun Wang; Bing Chen
Journal:  Cell Mol Neurobiol       Date:  2017-02-17       Impact factor: 5.046

4.  TRIM14 Is a Key Regulator of the Type I IFN Response during Mycobacterium tuberculosis Infection.

Authors:  Caitlyn T Hoffpauir; Samantha L Bell; Kelsi O West; Tao Jing; Allison R Wagner; Sylvia Torres-Odio; Jeffery S Cox; A Phillip West; Pingwei Li; Kristin L Patrick; Robert O Watson
Journal:  J Immunol       Date:  2020-05-13       Impact factor: 5.422

Review 5.  Signal transducer and activator of transcription 3 regulation by novel binding partners.

Authors:  Tadashi Matsuda; Ryuta Muromoto; Yuichi Sekine; Sumihito Togi; Yuichi Kitai; Shigeyuki Kon; Kenji Oritani
Journal:  World J Biol Chem       Date:  2015-11-26

6.  Aging-like changes in the transcriptome of irradiated microglia.

Authors:  Matthew D Li; Terry C Burns; Sunny Kumar; Alexander A Morgan; Steven A Sloan; Theo D Palmer
Journal:  Glia       Date:  2015-02-17       Impact factor: 7.452

7.  Innate lymphoid cell type 3-derived interleukin-22 boosts lipocalin-2 production in intestinal epithelial cells via synergy between STAT3 and NF-κB.

Authors:  Maarten Coorens; Anna Rao; Stefanie Katharina Gräfe; Daniel Unelius; Ulrik Lindforss; Birgitta Agerberth; Jenny Mjösberg; Peter Bergman
Journal:  J Biol Chem       Date:  2019-02-19       Impact factor: 5.157

Review 8.  Role of STAT3 in Genesis and Progression of Human Malignant Gliomas.

Authors:  Zangbéwendé Guy Ouédraogo; Julian Biau; Jean-Louis Kemeny; Laurent Morel; Pierre Verrelle; Emmanuel Chautard
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

Review 9.  Role of interleukin-6 in cancer progression and therapeutic resistance.

Authors:  Neeraj Kumari; B S Dwarakanath; Asmita Das; Anant Narayan Bhatt
Journal:  Tumour Biol       Date:  2016-06-03

Review 10.  Nuclear factor-κB in glioblastoma: insights into regulators and targeted therapy.

Authors:  Kirk E Cahill; Ramin A Morshed; Bakhtiar Yamini
Journal:  Neuro Oncol       Date:  2015-11-02       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.